India will administer injections to three million frontline workers in phase one. There are 3,006 session sites across the country, where every 100 recipients will receive either of the two indigenous vaccines from India, Covaxin or Covishield. Each beneficiary must receive two doses of the same vaccine, 28 days apart. …
Read More »
The Union Ministry of Health and Family Welfare has answered many of the public inquiries in the form of Frequently Asked Questions (FAQ) in its recently published document. The health ministry reiterated that vaccination against the coronavirus disease (Covid-19) is voluntary, however, it recommended that people receive the full dose …
Read More »
By: Express Web Desk | New Delhi | Updated: December 13, 2020 3:29:42 pm The executive director of the Serum Institute, Adar Poonawalla. (File photo) Serum Institute of India (SII) Executive Director Adar Poonawalla said the Covid-19 vaccination campaign would likely begin in India in January as his company, which …
Read More »
India’s coronavirus (Covid-19) count is approaching the 9.9 million mark with 30,254 new cases and 391 related deaths added in the past 24 hours. Amid a downward trend in active cases and an increase in the number of people recovering from the disease, states and union territories (UTs) are preparing …
Read More »
The new coronavirus (Covid-19) pandemic, which began nearly a year ago, has infected more than 72 million people and killed 1.6 million so far, according to worldometer figures. Several governments around the world, in collaboration with pharmaceutical companies, have carried out extensive work to develop vaccines that can eliminate this …
Read More »
India is yet to discuss the price of the Pfizer / BioNTech vaccine and the company’s ability to deliver the orders placed by the country, even as the Central Standard Drug Control Organization or CDSCO reviews the emergency authorization requested by the developer of the vaccine. A senior government official …
Read More »
The Serum Institute of India on Sunday became the first indigenous company to submit an application to the Comptroller General of Drugs of India (DCGI) seeking an emergency use authorization for the Oxford Covid-19 vaccine in the country citing needs. not covered due to the pandemic and in interest. from …
Read More »
Amid the increase in coronavirus cases in the country, Dr. Randeep Guleria, director of AIIMS and member of the national working group on the management of Covid-19, has said that we now have vaccines, which are in their stage of final test in India. Dr. Randeep Guleria is hoping for …
Read More »
Phase 3 clinical trials of Indian coronavirus vaccine manufacturer Bharat Biotech are conducted in partnership with the Indian Council for Medical Research (ICMR) lead medical body. Trials of its Covid-19 vaccine candidate, Covaxin, involving 26,000 participants at 22 sites across the country, began on November 16. It is the largest …
Read More »
The Oxford-AstraZeneca vaccine for coronavirus disease could be available to the general public between April and May next year and is likely to cost around ₹ 500-600 per dose, the executive director of the Serum Institute of India said on Thursday. , Adar Poonawalla, adding that he expects the long-awaited …
Read More »